Agapito Castilleja

Folate binding protein peptide 191-199 presented on dendritic cells can stimulate CTL from ovarian and breast cancer patients.

D K Kim, T V Lee, Agapito Castilleja et al. · PubMed · 2000 · 35 citations

Immunology, Immunologic Mechanism, Antigen Processing +19

Accelerated HER-2 degradation enhanced ovarian tumor recognition by CTL. Implications for tumor immunogenicity

Agapito Castilleja, Nancy E. Ward, Catherine A. O’Brian et al. · Molecular and Cellular Biochemistry · 2001 · 34 citations

Induction of Tumor-Reactive CTL by C-Side Chain Variants of the CTL Epitope HER-2/neu Protooncogene (369-377) Selected by Molecular Modeling of the Peptide: HLA-A2 Complex

Agapito Castilleja, Darrick Carter, Clay L. Efferson et al. · The Journal of Immunology · 2002 · 23 citations

Axillary Lymph Node Cellular Immune Response to HER-2/ <i>neu</i> Peptides in Patients with Carcinoma of the Breast

Henry M. Kuerer, George E. Peoples, Ayşegül A. Şahin et al. · Journal of Interferon & Cytokine Research · 2002 · 20 citations

Ovarian and breast cytotoxic T lymphocytes can recognize peptides from the amino enhancer of split protein of the Notch complex

Blake D. Babcock, B W Anderson, Ioannis A. Papayannopoulos et al. · Molecular Immunology · 1998 · 16 citations

Immunogenetics, Signal Transduction, Breast Cytotoxic T +9